Literature DB >> 7806391

Analysis of immunization route-related variation in the immune response to heat-killed Salmonella typhimurium in mice.

J Thatte1, S Rath, V Bal.   

Abstract

In examinations of the factors regulating the quality and quantity of the immune response to Salmonella typhimurium, we have shown previously that live and heat-killed preparations of S. typhimurium can induce gamma interferon-dominant and interleukin-4-dominant immune responses, respectively, upon intraperitoneal (i.p.) immunization of BALB/c mice. Using this system to investigate the role of the route of immunization in the immune response, we show in the present study that i.p. immunization with heat-killed S. typhimurium generates a quantitatively better immune response than does intradermal (i.d.) immunization. The quantitative differences observed between the i.p. and i.d. routes are apparent in the amount of S. typhimurium-specific antibodies produced, the extent of responses in T-cell proliferation assays, and the quantities of lymphokines generated. However, the ratios of immunoglobulin (Ig) isotypes [IgG1/IgG2a] are comparable and the relative dominance of interleukin-4 over gamma interferon is seen in both i.p.- and i.d.-immunized mice, suggesting that the predominant T-cell effector pathways triggered are not qualitatively dependent on the route of immunization. An examination of the antigenic profile recognised by the B-cell and T-cell responses in i.p.- versus i.d.-immunized mice shows that while the Western immunoblot patterns recognized by serum antibodies from the two groups of mice were not significantly different, T cells from i.p.-immunized mice recognized a broader spectrum of antigens in an immunoblot assay than did those from i.d.-immunized mice. These data suggest that there may be a significant difference in the antigen-processing ability of peritoneal and dermal antigen-presenting cells for complex antigenic formulations such as bacterial vaccines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7806391      PMCID: PMC172963          DOI: 10.1128/iai.63.1.99-103.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Route-related variation in immunogenicity of mycobacteria.

Authors:  K E Shroff; S R Sengupta; R S Kamat
Journal:  Int J Lepr Other Mycobact Dis       Date:  1990-03

2.  An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned beta-galactosidase in mice.

Authors:  A Brown; C E Hormaeche; R Demarco de Hormaeche; M Winther; G Dougan; D J Maskell; B A Stocker
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

3.  T lymphocytes respond to solid-phase antigen: a novel approach to the molecular analysis of cellular immunity.

Authors:  D B Young; J R Lamb
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

4.  The role of T-cell subsets and cytokines in the regulation of infection.

Authors:  P Scott; S H Kaufmann
Journal:  Immunol Today       Date:  1991-10

5.  Route-related variation in the immunogenicity of killed Salmonella enteritidis vaccine: role of antigen presenting cells.

Authors:  A George; K E Shroff; S Rath; S N Ghosh; S R Sengupta; R S Kamat
Journal:  Microbiol Immunol       Date:  1989       Impact factor: 1.955

6.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

7.  Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.

Authors:  J C Sadoff; W R Ballou; L S Baron; W R Majarian; R N Brey; W T Hockmeyer; J F Young; S J Cryz; J Ou; G H Lowell
Journal:  Science       Date:  1988-04-15       Impact factor: 47.728

8.  Immunization with live versus killed Salmonella typhimurium leads to the generation of an IFN-gamma-dominant versus an IL-4-dominant immune response.

Authors:  J Thatte; S Rath; V Bal
Journal:  Int Immunol       Date:  1993-11       Impact factor: 4.823

9.  Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.

Authors:  P Scott; P Natovitz; R L Coffman; E Pearce; A Sher
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

10.  Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein.

Authors:  T P Poirier; M A Kehoe; E H Beachey
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  13 in total

1.  Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination.

Authors:  Lena Strindelius; Lena Degling Wikingsson; Ingvar Sjöholm
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

2.  Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgA.

Authors:  Jin Qiu; Lin Yan; Jianbo Chen; Crystal Y Chen; Ling Shen; Norman L Letvin; Barton F Haynes; Nancy Freitag; Lijun Rong; James T Frencher; Dan Huang; Xunming Wang; Zheng W Chen
Journal:  Clin Vaccine Immunol       Date:  2011-01-26

3.  Epitope-specific immune recognition of the nontypeable Haemophilus influenzae outer membrane protein 26.

Authors:  Duangkamol Kunthalert; Laura A Novotny; Helen M Massa; Glen C Ulett; Lauren O Bakaletz; Jennelle M Kyd; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

4.  Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major.

Authors:  Flavia L Ribeiro-Gomes; Eric Henrique Roma; Matheus B H Carneiro; Nicole A Doria; David L Sacks; Nathan C Peters
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

5.  Development of a recombinant epsilon toxoid vaccine against enterotoxemia and its use as a combination vaccine with live attenuated sheep pox virus against enterotoxemia and sheep pox.

Authors:  Dev Chandran; Sureddi Satyam Naidu; Parthasarathy Sugumar; Gudavalli Sudha Rani; Shahana Pallichera Vijayan; Deepika Mathur; Lalit C Garg; Villuppanoor Alwar Srinivasan
Journal:  Clin Vaccine Immunol       Date:  2010-04-28

6.  Immunomodulatory properties of porins of some members of the family Enterobacteriaceae.

Authors:  V Alurkar; R Kamat
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

7.  Efficacy of a Lactococcus lactis ΔpyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes.

Authors:  Mohammed Bahey-El-Din; Pat G Casey; Brendan T Griffin; Cormac Gm Gahan
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

8.  Th1 and Th2 cell involvement in immune response to Salmonella typhimurium porins.

Authors:  M Galdiero; L De Martino; A Marcatili; I Nuzzo; M Vitiello; G Cipollaro de l'Ero
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

9.  Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis.

Authors:  Rajesh Mani; Manish Gupta; Anshu Malik; Ravi Tandon; Rajendra Prasad; Rakesh Bhatnagar; Nirupama Banerjee
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

10.  An empirical approach towards the efficient and optimal production of influenza-neutralizing ovine polyclonal antibodies demonstrates that the novel adjuvant CoVaccine HT™ is functionally superior to Freund's adjuvant.

Authors:  Natalie E Stevens; Cara K Fraser; Mohammed Alsharifi; Michael P Brown; Kerrilyn R Diener; John D Hayball
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.